SecSonar.com

Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Tilray Brands, Inc. (TLRY) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $667.2M. Revenue grew 4.8% year-over-year and free cash flow was negative at -$175M. This page tracks TLRY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 2.65K employees · IPO Jul 19, 2018

Valuation

Valuation & price

$5.32 · as of May 17, 2026 · -74.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.32

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$17.30$10.95$4.59Jul 25Dec 25Jul 26Jul 7, 25$5.03Jul 9, 25$6.75Jul 11, 25$5.81Jul 15, 25$5.93Jul 17, 25$6.11Jul 21, 25$6.74Jul 23, 25$7.36Jul 25, 25$6.89Jul 29, 25$5.77Jul 31, 25$5.81Aug 4, 25$6.08Aug 6, 25$6.17Aug 11, 25$9.20Aug 13, 25$12.50Aug 15, 25$10.30Aug 19, 25$10.60Aug 21, 25$11.10Aug 25, 25$13.90Aug 27, 25$13.70Aug 29, 25$13.80Sep 3, 25$11.90Sep 5, 25$11.90Sep 9, 25$11.40Sep 11, 25$10.60Sep 16, 25$12.20Sep 18, 25$12.60Sep 22, 25$12.00Sep 24, 25$12.60Sep 26, 25$11.50Sep 30, 25$17.30Oct 2, 25$16.10Oct 6, 25$15.80Oct 8, 25$17.20Oct 10, 25$17.20Oct 14, 25$16.00Oct 16, 25$15.40Oct 21, 25$14.80Oct 23, 25$14.80Oct 27, 25$14.70Oct 29, 25$13.60Oct 31, 25$13.40Nov 4, 25$12.40Nov 6, 25$12.10Nov 10, 25$13.10Nov 12, 25$12.30Nov 14, 25$10.80Nov 18, 25$10.30Nov 20, 25$8.99Nov 25, 25$9.83Nov 28, 25$8.13Dec 2, 25$7.71Dec 4, 25$7.22Dec 8, 25$7.20Dec 10, 25$8.26Dec 12, 25$12.15Dec 16, 25$13.94Dec 18, 25$12.34Dec 22, 25$10.42Dec 24, 25$10.15Dec 29, 25$9.26Jan 2, 26$9.72Jan 6, 26$9.26Jan 8, 26$9.13Jan 12, 26$9.30Jan 14, 26$9.90Jan 16, 26$9.46Jan 21, 26$8.67Jan 23, 26$9.05Jan 27, 26$8.42Jan 29, 26$7.62Feb 2, 26$7.44Feb 4, 26$7.60Feb 9, 26$7.70Feb 11, 26$7.62Feb 13, 26$7.51Feb 18, 26$7.58Feb 20, 26$7.75Feb 24, 26$7.92Feb 26, 26$7.99Mar 2, 26$7.60Mar 4, 26$7.30Mar 6, 26$7.21Mar 10, 26$7.20Mar 12, 26$6.95Mar 17, 26$6.95Mar 19, 26$6.66Mar 23, 26$6.45Mar 25, 26$6.94Mar 27, 26$6.32Mar 31, 26$6.47Apr 2, 26$6.55Apr 7, 26$6.46Apr 9, 26$6.72Apr 13, 26$6.72Apr 15, 26$6.95Apr 17, 26$6.86Apr 22, 26$7.87Apr 24, 26$6.75Apr 28, 26$6.56Apr 30, 26$6.24May 4, 26$5.90May 6, 26$5.76May 8, 26$5.56May 12, 26$5.41May 14, 26$5.50May 18, 26$5.18May 20, 26$5.41May 22, 26$5.29May 28, 26$5.65Jun 1, 26$5.49Jun 3, 26$5.11Jun 5, 26$4.94Jun 9, 26$5.17Jun 11, 26$5.12Jun 15, 26$5.01Jun 17, 26$4.75Jun 22, 26$4.59Jun 24, 26$4.59Jun 26, 26$4.64Jul 2, 26$4.62
$4.4352-week range$21.00
Loading valuation history…

Fundamentals

Key fundamentals

$667.2M

Market cap

4.8%

Revenue growth (YoY)

29.3%

Gross margin

-$175M

Free cash flow (USD)

$99.3M

Net debt

19.9%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$6.5MFY 2017$15.2MFY 2018$28.6MFY 2019$179.3MFY 2020$405.3MFY 2021$619.7MFY 2022$792.1MFY 2023$844.7MFY 2024$1.1BFY 2025$1.1B
$6.5M$1.1B

Free cash flow by year

2016 → 2025

FY 2016$-4.2MFY 2017$-5.1MFY 2018$-21.5MFY 2019$-131.3MFY 2020$-442.0MFY 2021$-100.9MFY 2022$-266.4MFY 2023$-17.4MFY 2024$-82.0MFY 2025$-175.0M
-$4.2M-$175M

Gross margin by year

2021 → 2025

FY 202124.0%FY 202218.6%FY 202323.4%FY 202428.3%FY 202529.3%
24.0%29.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity IssuanceJun 30, 2026Filing
  • 8-K eventEquity IssuanceJun 9, 2026Filing
  • Insider sellInsider Sell $233KHopkinson David G. · Director · $232.9KApr 22, 2026Filing
  • 8-K eventShare OfferingApr 21, 2026Filing
  • 8-K eventDebt-for-Equity ExchangeApr 15, 2026Filing
  • 8-K eventStock Offering AgreementApr 15, 2026Filing
  • 8-K eventEarnings ReleaseApr 1, 2026Filing
  • Quarterly report10-Q FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is Tilray Brands, Inc.'s market cap?

Tilray Brands, Inc. (TLRY) has a market capitalization of $667.2M.

What is TLRY's P/E ratio?

A meaningful P/E ratio is not available for TLRY — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TLRY's price-to-book (P/B) ratio?

TLRY trades at 0.32 times book value per share.

Are insiders buying TLRY stock?

SEC Form 4 filings show no open-market insider buys at Tilray Brands, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

IRWD

Ironwood Pharmaceuticals, Inc.

$582M

AMPH

Amphastar Pharmaceuticals, Inc.

$826.3M

CGC

Canopy Growth Corporation

$468.3M

KMDA

Kamada Ltd.

$451.4M

EOLS

Evolus, Inc.

$434.3M

PCRX

Pacira BioSciences, Inc.

$925.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.